TETRAGENEX PHARMACEUTICALS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$1.7M

13 transactions

Summary

TETRAGENEX PHARMACEUTICALS, INC. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $7KSales: —10 insiders

Date	Insider	Type	Value
2007-07-26	Cartwright Kenneth(Chief Scientific Officer)	A	$500K
2007-07-26	COMER WILLIAM T	A	$350K
2007-07-26	Budetti Robert Peter	A	$350K
2007-07-26	Abel David(CO-CEO)	A	$300K
2007-07-26	COHEN AARON	A	$225K
2007-11-26	COHEN AARON	Buy	$4K
2007-11-29	COHEN AARON	Buy	$2K
2007-11-29	COHEN AARON	Buy	$2K
2007-07-26	Akerman Alf E F	A	$0
2007-07-26	Martucci Neil(CFO)	A	$0
2007-07-26	Hamlin John W JR(Secretary/Treasurer)	A	$0
2007-07-26	Bergman Bruce J	A	$0
2007-07-26	SCHACKER MARTIN F(Co-CEO)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

TETRAGENEX PHARMACEUTICALS, INC. — Contributions, Lobbying & Contracts | Poliscope